Impact of Human Papillomavirus Carriage on IVF/ICSI Results at Brest University Hospital
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The prevalence of the papilloma virus in the general population is 12%. This virus is known to impair male fertility but its impact on female infertility remains uncertain. This is a public health problem since there is a vaccination protocol. Demonstrating the impact of the human papillomavirus on fertility would be an argument in favor of vaccination.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 25
Maximum Age: 38
Healthy Volunteers: f
View:
• all etiology of infertility AMH \> ou = à 1.1 ng/ml First ou second protocol of IVF between 25 years and 37 years and 11 months
Locations
Other Locations
France
CHRU de Brest
RECRUITING
Brest
Contact Information
Primary
Sarah BOUEE
sarah.bouee@chu-brest.fr
02 98 22 39 70
Backup
Anne-Solenn JACAMON
anne-solenn.jacamon@chu-brest.fr
Time Frame
Start Date: 2022-02-04
Estimated Completion Date: 2026-02-04
Participants
Target number of participants: 618
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Brest